Agenus

  • Research Associate (Senior) - Cell Line Development

    Job Locations UK-Cambridge
    Posted Date 2 months ago(5/16/2018 2:46 AM)
    ID
    2018-1398
    Category
    Research
  • Overview

    Agenus is a pioneer in the emerging field of Immuno-oncology. For two decades, Agenus has been creating and advancing patient-specific anticancer vaccines in the effort to harness the power of the immune system to control or eradicate cancer. We now have a portfolio of innovative approaches that include checkpoint modulators, personalized anticancer vaccines and powerful adjuvants. We are dedicated scientists, researchers, biotechnologists, physicians, and businesspeople working together toward one goal: minimize the burden of cancers and infections by helping the body heal itself through the power of science.

     

    The work we do at Agenus is cutting edge and deeply motivating. We believe passionately in our technology, in our pipeline, and in our responsibility to deliver on the promise of immunology to treat cancer and infectious disease. Our environment fosters innovation and leadership at every level. We encourage people to think and dream big. We provide the opportunity to apply your many talents and develop your career in creative and sometimes unconventional ways. If you’re looking for an inspired environment, passionate colleagues, and a culture that nurtures learning, innovation and team success, we invite you to join us.

     

    As a Cell Line Development Research Associate within the Cell Line Development team you will contribute to advancing CLD projects to support the generation of therapeutic biologics.

    We have an exciting opportunity for a Research Associate/Senior Research Associate to join our Cell Line Development Team in Cambridge.

    This is a state of the art facility located in the centre of Cambridge specialised in the development of biopharmaceuticals of Immuno Oncology targets. 

    You will be part of a global team, with opportunities to grow within the company.

     

     

     

    Responsibilities

    • Perform stable cell line development projects in timely manner including construction of expression vectors, transfections, selection of clones, maintenance of cell cultures, cryopreservation and cell line clonality
    • Expression and quantification of recombinant proteins
    • Accurate data analysis and recording to insure full traceability
    • Write Working Instructions and technical reports
    • Prepare presentations and communicate the results to the team
    • Liaise and coordinate CLD projects with Process Development and Process Analytical groups
    • Optimize, evaluate and implement novel methods and technologies for process improvement
    • Participate at laboratory tasks as maintenance of equipment, ordering
    • Understand and adhere to corporate standards regarding code of conduct, safety, appropriate handling of materials, controlled drug, GxP compliance, where applicable

    Qualifications

    • MSc in molecular biology, biotechnology, biochemistry or related discipline

     

    Experience:

    • 1 - 3 years of relevant experience in a biotech or pharmaceutical company preferred
    • Practical knowledge of working with mammalian cell culture techniques
    • Practical experience in developing stable cell lines is a bonus
    • Molecular biology skills (PCR, vector construction, Northern blot)
    • Experience with automation in cell culture and product analysis (FACS, Octet, Biacore) is highly desirable

     

    Profile:

    • Excellent analytical skills and good attention to details
    • Ability to work independently and in a team
    • Excellent communication skills with presentation of data, ability to share experience with others and communicate effectively to senior management
    • Outstanding organizational and multi-tasking skills; ability to manage several projects/cell lines simultaneously and to adjust to changing priorities

    Options

    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed